Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose comparison of remimazolam vs propofol for induction of general anesthesia in elderly patients
ChiCTR2100047794Phase 4Not yet recruiting
- Sponsor
- Linfen Central Hospital
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of remimazolam (4 arms), sponsored by Linfen Central Hospital. Primary endpoints: Time from induction of anesthesia to BIS ≤60 and Diastolic blood pressure. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2100047794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047794.